Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Angiotensin receptor neprilysi...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Export Ready — 
Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)

Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)

Bibliographic Details
Main Authors: Berkay Ekici, Mehmet Yaman, Murathan Küçük, Seçkin Dereli, Mustafa Yenerçağ, Zerrin Yiğit, Mehmet Memduh Baş, Yusuf Karavelioğlu, Hüseyin Altuğ Çakmak, Tarık Kıvrak, Hakan Özkan, Cihan Altın, Cengiz Şabanoğlu, Burcu Demirkan, Ali Ekber Ataş, Fethi Kılıçaslan, Hakan Altay, İstemihan Tengiz, Aycan Fahri Erkan, Barış Kılıçaslan, Fatih Erkam Olgun, Murtaza Emre Durakoğlugil, Aslıhan Alhan, Mehdi Zoghi
Format: Article
Language:English
Published: KARE Publishing 2021-07-01
Series:Türk Kardiyoloji Derneği Arşivi
Online Access:https://archivestsc.com/jvi.aspx?un=TKDA-63099&volume=49&issue=5
  • Holdings
  • Description
  • Similar Items
  • Staff View
Description
ISSN:1016-5169

Similar Items

  • Will we ever use angiotensin receptor neprilysin inhibition (ARNi) for the treatment of hypertension?
    by: Sverre E. Kjeldsen, et al.
    Published: (2019-03-01)
  • Safety and effectiveness of angiotensin receptor-neprilysin inhibitors (ARNI) in patients with heart failure with preserved ejection fraction (HFPEF) – ‘ARNI-preserved’ study
    by: Pankaj Jariwala, et al.
    Published: (2021-12-01)
  • Practical Recommendations for the Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Heart Failure: Insights from Indian Cardiologists
    by: Jamshed Dalal, et al.
    Published: (2023-06-01)
  • Anti-hypertensive effect of a novel angiotensin II receptor neprilysin inhibitor (ARNi) -S086 in DSS rat model
    by: Jingchao Sun, et al.
    Published: (2024-02-01)
  • Real-world experience of angiotensin receptor/neprilysin inhibitor (ARNI) usage in Thailand: a single-center, retrospective analysis
    by: Wipharak Rattanavipanon, et al.
    Published: (2021-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs